Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vincerx Pharma, Inc. (VINC) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vincerx Pharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1796129.
Total stock buying since 2021: $574,272.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 54,276 | $50,799 | 0 | $0 | 0 | $0 |
| 2022 | 180,218 | $230,325 | 0 | $0 | 0 | $0 |
| 2021 | 26,269 | $293,148 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-08 | 54,276 | $50,799 | 0 | $0 | 0 | $0 |
| 2022-12 | 71,018 | $61,795 | 0 | $0 | 0 | $0 |
| 2022-08 | 30,000 | $49,444 | 0 | $0 | 0 | $0 |
| 2022-06 | 79,200 | $119,086 | 0 | $0 | 0 | $0 |
| 2021-12 | 15,269 | $155,036 | 0 | $0 | 0 | $0 |
| 2021-08 | 1,000 | $11,960 | 0 | $0 | 0 | $0 |
| 2021-06 | 10,000 | $126,152 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-11 | Seelenberger Alexander A. (See Remarks) | Buy | 10,500 | .95 | 9,964 |
| 2023-08-10 | Izumi Raquel E. (See Remarks) | Buy | 3,440 | .93 | 3,199 |
| 2023-08-10 | Hamdy Ahmed Md (See Remarks) | Buy | 5,400 | .96 | 5,167 |
| 2023-08-10 | Thomas Tom C (See Remarks) | Buy | 5,000 | .95 | 4,750 |
| 2023-08-09 | Izumi Raquel E. (See Remarks) | Buy | 13,036 | .90 | 11,732 |
| 2023-08-09 | Hamdy Ahmed Md (See Remarks) | Buy | 16,900 | .95 | 15,987 |
| 2022-12-14 | Izumi Raquel E. (See Remarks) | Buy | 28,738 | .89 | 25,433 |
| 2022-12-14 | Hamdy Ahmed Md (Chief Executive Officer) | Buy | 35,280 | .87 | 30,552 |
| 2022-12-14 | Thomas Tom C (See Remarks) | Buy | 7,000 | .83 | 5,810 |
| 2022-08-25 | Lowe Christopher P. (Director) | Buy | 11,600 | 1.65 | 19,140 |
| 2022-08-24 | Lowe Christopher P. (Director) | Buy | 18,400 | 1.65 | 30,304 |
| 2022-06-27 | Izumi Raquel E. (See Remarks) | Buy | 40,000 | 1.41 | 56,320 |
| 2022-06-23 | Hamdy Ahmed Md (Chief Executive Officer) | Buy | 24,200 | 1.41 | 34,146 |
| 2022-06-09 | Bushnell Laura I. (Director) | Buy | 15,000 | 1.91 | 28,620 |
| 2021-12-23 | Hwang Sooin (Chief Business Officer) | Buy | 3,000 | 10.00 | 30,000 |
| 2021-12-22 | Bushnell Laura I. (Director) | Buy | 2,402 | 10.48 | 25,172 |
| 2021-12-22 | Seelenberger Alexander A. (Chief Financial Officer) | Buy | 2,417 | 10.34 | 24,986 |
| 2021-12-22 | Hamdy Ahmed Md (Chief Executive Officer) | Buy | 6,450 | 10.02 | 64,648 |
| 2021-12-22 | Thomas Tom C (See Remarks) | Buy | 1,000 | 10.23 | 10,230 |
| 2021-08-04 | Izumi Raquel E. (See Remarks) | Buy | 1,000 | 11.96 | 11,960 |
| 2021-06-30 | Lowe Christopher P. (Director) | Buy | 3,600 | 12.66 | 45,576 |
| 2021-06-29 | Lowe Christopher P. (Director) | Buy | 6,400 | 12.59 | 80,576 |
Insider trading activities including stock purchases, stock sales, and option exercises of VINC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vincerx Pharma, Inc. (symbol VINC, CIK number 1796129) see the Securities and Exchange Commission (SEC) website.